GE HealthCare Adds AI Features to Vscan Air Ultrasound

Chicago, Illinois, United States, November 3, 2026

Lung Guidance Improves Point-of-Care Ultrasound Imaging

The new Lung Guidance capability is designed to support clinicians during lung ultrasound examinations by providing real-time instructions for probe positioning and image acquisition. The software guides users toward anatomical landmarks across the standard eight-zone lung ultrasound protocol, helping them capture diagnostic-quality images more consistently. The AI system identifies important anatomical structures and ultrasound features, including the pleural line, A-lines, rib shadows, diaphragm and abdomen. When predefined anatomical landmark and image-quality requirements are met, the integrated AutoCapture function automatically records an ultrasound clip. A separate Save Best Clip feature enables clinicians to retain the highest-quality image from each scanning view when automatic capture conditions are not achieved. In addition, Lung Guidance supports B-line detection and scoring, helping clinicians organize findings from lung ultrasound examinations. B-lines are vertical ultrasound artifacts that can provide useful information when evaluating certain pulmonary conditions, including interstitial lung abnormalities and pulmonary congestion. GE HealthCare reported that validation testing demonstrated a 95.2% success rate among non-expert users in acquiring diagnostic-quality lung ultrasound examinations, compared with 96.8% among expert users. These results were based on a descriptive assessment and indicate the potential of AI-guided imaging to support clinicians with different levels of ultrasound experience.

AutoAS Supports Assessment of Aortic Stenosis

The second capability, AutoAS, is designed to provide an AI-assisted visual estimate of whether ultrasound findings suggest moderate-to-severe aortic stenosis. Aortic stenosis occurs when the aortic valve becomes narrowed, restricting blood flow from the heart to the rest of the body. The condition can cause symptoms such as chest discomfort, breathlessness, dizziness and fainting, particularly as the disease progresses. AutoAS analyzes standard two-dimensional cardiac ultrasound images acquired using the Vscan Air SL system. The software requires at least two compatible echocardiographic views, including parasternal long-axis, parasternal short-axis at the aortic valve or apical five-chamber views. Based on these images, the AI algorithm provides an estimate indicating whether findings are suggestive of moderate-to-severe aortic stenosis, together with a confidence score reflecting the algorithm’s certainty. The technology was trained and validated against assessments from a reference panel of expert cardiologists. According to GE HealthCare, AutoAS may help reduce variability associated with missed cases compared with visual interpretation alone. Importantly, AutoAS is intended as a diagnostic aid and not a standalone diagnostic tool. Its output must be interpreted by qualified clinicians alongside comprehensive echocardiographic assessment and clinical judgment. The technology is particularly intended to support early assessment when access to formal echocardiography or specialist interpretation may be delayed.

GE HealthCare Expands Its AI Ultrasound Portfolio

The introduction of Lung Guidance and AutoAS builds on GE HealthCare’s existing AI capabilities within the Vscan Air cardiopulmonary suite, including Caption AI for cardiac scan guidance and Caption Interpretation Auto EF for ejection fraction assessment. Together, these technologies are intended to provide additional support when clinicians evaluate patients with potentially overlapping cardiac and respiratory symptoms. The company is also expanding AI capabilities across its broader point-of-care ultrasound portfolio, including the Venue and LOGIQ e product families. This strategy reflects the growing importance of AI-assisted medical imaging in improving workflow consistency and supporting clinical decision-making across different healthcare environments. Both new capabilities are available through Vscan Air Innovation Packages in the United States and selected countries, with availability depending on location and system model. Existing customers with a valid Innovation Package subscription or license are expected to receive the updates by the end of November 2026. Overall, GE HealthCare’s latest announcement highlights the growing role of AI-powered handheld ultrasound technology in cardiovascular and respiratory assessment. By combining image acquisition guidance with automated assessment support, the company aims to bring additional imaging capabilities closer to patients and clinicians. These innovations could help improve the consistency of point-of-care ultrasound examinations while supporting earlier clinical evaluation.

Source: GE HealthCare press release